Empery Asset Management, LP 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-28 2:25 pm Sale |
2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Empery Asset Management, LP | 4,022 3.900% |
-2,228 (-35.65%) |
Filing |
| 2020-08-04 09:18 am Purchase |
2020-07-30 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Empery Asset Management, LP | 6,250 6.900% |
6,250 (New Position) |
Filing |